Suchergebnisse - "Knapper, Steven"

PubPharm (6)

1

A randomised evaluation of low-dose Ara-C plus pegylated recombinant arginase BCT-100 versus low dose Ara-C in older unfit patients with acute myeloid leukaemia : Results from the LI-1 trial

enthalten in: British journal of haematology | 2023

von Mussai, F. | De Santo, C. | Cheng, P. | +13

2

Use of an anti-CD200-blocking antibody improves immune responses to AML in vitro and in vivo

enthalten in: British journal of haematology | 2021

von Rastogi, N. | Baker, S. | Man, S. | +8

3

Telomere length is an independent prognostic marker in MDS but not in de novo AML

enthalten in: British journal of haematology | 2017

von Williams, J. | Heppel, N. | Britt-Compton, B. | +10

4

Telomere length is an independent prognostic marker in MDS but not in de novo AML

enthalten in: British journal of haematology | 2017

von Williams, J. | Heppel, N. | Britt‐Compton, B. | +10

5

The targeted histone deacetylase inhibitor tefinostat (CHR-2845) shows selective in vitro efficacy in monocytoid-lineage leukaemias

enthalten in: Oncotarget | 2016

von Zabkiewicz, J. | Gilmour, M. | Hills, R. | +5

6

Elacytarabine in relapsed/refractory acute myeloid leukaemia : an evaluation of clinical efficacy, pharmacokinetics, cardiac safety and effects on lipid profile

enthalten in: Leukemia research | 2014

von Knapper, S. | Chevassut, T. | Duarte, R. | +8

1
[1]